The Russian government has extended the permit for domestic pharmaceutical companies Promomed and PSK Pharma to produce ...

Japanese pharma Daiichi Sankyo (TSE: 4568) and British partner AstraZeneca (LSE: AZN) said Enhertu (trastuzumab deruxtecan) ...

US biopharma Corcept Therapeutics (Nasdaq: CORT) says its Phase III ROSELLA trial met its overall survival primary endpoint ...

Japanese drugmaker Daiichi Sankyo has appointed Veronika Rozehnal to succeed Jürgen Müller as the Head of the Translational ...

Janux Therapeutics’ shares closed up 14% at $15.14, after it announced a collaboration and exclusive worldwide license ...

USA-based Medicus Pharma’ Antev subsidiary has agreed to amend its licensing deal with UK-based medical research organization LifeArc relating to teverelix, an investigational next generation ...

Privately-held UK drug developer Ellipses Pharma has entered into a collaboration and licence agreement with China-based Innolake Biopharm to develop a clinical stage first-in-class antibody drug ...

UK pharma major GSK’s Nucala (mepolizumab) has recently received approval in China as add-on maintenance treatment for adults ...

The Gates Foundation, Novo Nordisk Foundation, and Wellcome have said they will award $60 million in new grant funding over ...

San Francisco-based Mendra, a biopharma aiming to advance promising therapies for rare disease medicines, has announced its ...

US clinical-stage biotech Corxel Pharmaceuticals, dedicated to developing innovative therapies for patients with ...

DelveInsight says the cystinosis treatment market across the USA, EU4, UK and Japan totaled about $250 million in 2024, with ...